BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
TDB Backs IIT-Guwahati-based Primary Healthtech’s AI-Powered Mobilab Blood Testing Device August 19, 2025 TDB has signed an agreement with Primary Healthtech to back Mobilab, an AI-powered, IoT-enabled portable blood testing device developed by IIT Guwahati alumni.
CDSCO Releases Revised Risk Classification List for Cardiovascular Devices April 4, 2025 The CDSCO has issued a revised risk classification list for 553 cardiovascular and neurological devices under the Medical Device Rules, 2017. Industry stakeholders are invited to submit feedback by April 30.
Alcon Unveils India’s First Fully Personalized LASIK Treatment with CDSCO Approval April 4, 2025 Alcon introduces Wavelight Plus, India's first fully personalized LASIK treatment, approved by CDSCO and the FDA. This offers precision vision correction using Ray Tracing Technology.
CDSCO Launches Online Portal for MSMEs to Seek Extension on Revised Schedule M Implementation March 25, 2025 Following the Health Ministry's latest notification, the CDSCO has introduced an online application system for MSME pharma units to request an extension on Revised Schedule M implementation.
CDSCO Launches Online Registration for Clinical Research Organizations March 6, 2025 CDSCO has launched an online registration portal for clinical research organizations (CROs). Registration is mandatory starting April 1, 2025, and applications must be submitted through the Sugam portal.
CDSCO Launches Online Portal for GMP Certificate Issuance & Verification March 3, 2025 CDSCO to introduce an online system for WHO GMP certification, streamlining verification and reducing delays in global pharmaceutical registrations.
CDSCO Moves Clinical Trial Applications to Online Portal January 3, 2025 CDSCO has transitioned the clinical trial site addition and change of principal investigator application process to the Sugam portal. The move aims to streamline the submission procedure for clinical trials in India.
SSI Mantra Becomes First CDSCO Certified Robotic System for Telesurgery in India December 10, 2024 SS Innovations’ SSI Mantra becomes the first surgical robotic system in India to receive CDSCO approval for telesurgery and teleproctoring, revolutionising access to advanced healthcare.
India's Drug Regulatory Process 95% Digitised: Health Minister October 15, 2024 Union Health Minister JP Nadda announced 95% digitisation of India's drug regulatory processes, boosting transparency and efficiency in drug approvals and quality control.
CDSCO Becomes Affiliate Member of International Medical Device Regulators Forum October 4, 2024 CDSCO joins the IMDRF as an Affiliate Member, enhancing India's medical device regulatory system and fostering global collaboration.
IPA Defends Members After CDSCO Flags Quality Failures October 1, 2024 The Indian Pharma Alliance defended its members after CDSCO flagged 53 commonly used medicines for quality failures in its August 2024 report.
Over 50 Drugs, Including Supplements, Fail Quality Tests by India’s Drug Regulator September 26, 2024 The CDSCO identified 53 drugs as Not of Standard Quality (NSQ) through its routine random sampling process conducted by state drug officers.
